Consainsights logo
Reports / Pneumonia Treatment Market

Pneumonia Treatment Market

Pneumonia Treatment Market Research Report – Segmented By Drug Type (Aminopenicilin, Cephalosporins, Glycopeptide Antibiotics, Macrolide, Others, Quinolone), Distribution Channel (Hospital Pharmacies, Others, Retail Pharmacies) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Pneumonia Treatment Market was valued at US $593.81 million in 2021 and is projected to grow at 6.59% CAGR over the forecast period to reach US $870.87 million by 2027. Pneumonia Treatment Market represented US $71.16 million opportunity over 2019-2021 and estimated to create US $277.06 million opportunity in 2027 over 2021.

Pneumonia Treatment from Consainsights analyses the Pneumonia Treatment Market in the Life Sciences industry over the forecast period to 2027.

Pneumonia Treatment research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Pneumonia Treatment segmentation includes Drug Type, Distribution Channel and Geography.

Based on the Drug Type, the Pneumonia Treatment analysis covers Quinolone, Macrolide, Aminopenicilin, Cephalosporins, Glycopeptide Antibiotics, Others.

In Drug Type segment, Quinolone segment has highest cagr growth of 5.84%.

Based on the Distribution Channel, the Pneumonia Treatment analysis covers Hospital Pharmacies, Retail Pharmacies, Others.

In Distribution Channel segment, Hospital Pharmacies segment has highest cagr growth of 5.84%.

Based on the region, the Pneumonia Treatment analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Abbott, Allergan, Akorn Inc., Baxter International Inc., Lupin Pharmaceuticals Inc., Mylan Inc., Neopharma, Novartis AG, Pfizer Inc., Teva Pharmaceuticals Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

  • Revenue Share (%), By Drug Type (2021)
    Revenue Share (%), By Drug Type (2021)
  • Revenue Share (%), By Distribution Channel (2021)
    Revenue Share (%), By Distribution Channel (2021)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Drug Type

  • Quinolone accounted for US$225.98 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Macrolide accounted for US$141.28 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Aminopenicilin accounted for US$96.74 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Cephalosporins accounted for US$66.35 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Glycopeptide Antibiotics accounted for US$42.54 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Others accounted for US$20.93 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Pneumonia Treatment Market Y-o-Y Growth (USD million), By Drug Type 2019 - 2027
Pneumonia Treatment Market Y-o-Y Growth (USD million), By Drug Type 2019 - 2027
Pneumonia Treatment Market Size, By Drug Type, 2019-2027 (USD million)
Pneumonia Treatment Market Size, By Drug Type, 2019-2027 (USD million)

The Aminopenicilin segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Aminopenicilin: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)
Aminopenicilin: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)

The Cephalosporins segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Cephalosporins: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)
Cephalosporins: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)

The Glycopeptide Antibiotics segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Glycopeptide Antibiotics: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)
Glycopeptide Antibiotics: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)

The Macrolide segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Macrolide: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)
Macrolide: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)

The Others segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Others: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)
Others: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)

The Quinolone segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Quinolone: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)
Quinolone: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)
04

By Distribution Channel

  • Hospital Pharmacies accounted for US$274.58 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Retail Pharmacies accounted for US$300.52 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Others accounted for US$18.71 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Pneumonia Treatment Market Y-o-Y Growth (USD million), By Distribution Channel 2019 - 2027
Pneumonia Treatment Market Y-o-Y Growth (USD million), By Distribution Channel 2019 - 2027
Pneumonia Treatment Market Size, By Distribution Channel, 2019-2027 (USD million)
Pneumonia Treatment Market Size, By Distribution Channel, 2019-2027 (USD million)

The Hospital Pharmacies segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Hospital Pharmacies: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)
Hospital Pharmacies: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)

The Others segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Others: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)
Others: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)

The Retail Pharmacies segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Retail Pharmacies: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)
Retail Pharmacies: global Pneumonia Treatment Market Revenue Opportunity (Us$ Mn)
05

North America

  • In 2021, North America segment accounted for US$593.81 Bn and is expected grow with a CAGR of 6.59% over the forecast years.
  • In North America, United States accounted for US$292.66 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Canada accounted for US$301.15 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
North America Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
North America Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
North America Pneumonia Treatment Market - Market Opportunity (USD million), 2019, 2021 & 2027
North America Pneumonia Treatment Market - Market Opportunity (USD million), 2019, 2021 & 2027
Revenue Share (%), By Drug Type - North America (2021)
Revenue Share (%), By Drug Type - North America (2021)
Revenue Share (%), By Distribution Channel - North America (2021)
Revenue Share (%), By Distribution Channel - North America (2021)
North America Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
North America Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
United States Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
United States Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
United States Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
United States Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Canada Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Canada Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Canada Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Canada Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
06

Europe

  • In 2021, Europe segment accounted for US$593.81 Bn and is expected grow with a CAGR of 6.59% over the forecast years.
  • In Europe, Germany accounted for US$230.54 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • United Kingdom accounted for US$144.86 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • France accounted for US$95.72 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Spain accounted for US$51.57 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Russia accounted for US$23.49 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Italy accounted for US$27.77 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Europe accounted for US$19.86 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Europe Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
Europe Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
Europe Pneumonia Treatment Market - Market Opportunity (USD million), 2019, 2021 & 2027
Europe Pneumonia Treatment Market - Market Opportunity (USD million), 2019, 2021 & 2027
Revenue Share (%), By Drug Type - Europe (2021)
Revenue Share (%), By Drug Type - Europe (2021)
Revenue Share (%), By Distribution Channel - Europe (2021)
Revenue Share (%), By Distribution Channel - Europe (2021)
Europe Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
Europe Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
Germany Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Germany Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Germany Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Germany Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
United Kingdom Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
United Kingdom Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
United Kingdom Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
United Kingdom Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
France Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
France Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
France Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
France Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Spain Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Spain Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Spain Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Spain Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Russia Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Russia Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Russia Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Russia Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Italy Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Italy Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Italy Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Italy Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Europe Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Europe Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Europe Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Europe Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
07

Asia-Pacific

  • In 2021, Asia-Pacific segment accounted for US$593.81 Bn and is expected grow with a CAGR of 6.59% over the forecast years.
  • In Asia-Pacific, China accounted for US$244.63 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Japan accounted for US$156.46 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • India accounted for US$101.81 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Southeast Asia accounted for US$42.46 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Australia & New Zealand accounted for US$27.48 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Asia-Pacific accounted for US$20.99 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Asia-Pacific Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
Asia-Pacific Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
Asia-Pacific Pneumonia Treatment Market - Market Opportunity (USD million), 2019, 2021 & 2027
Asia-Pacific Pneumonia Treatment Market - Market Opportunity (USD million), 2019, 2021 & 2027
Revenue Share (%), By Drug Type - Asia-Pacific (2021)
Revenue Share (%), By Drug Type - Asia-Pacific (2021)
Revenue Share (%), By Distribution Channel - Asia-Pacific (2021)
Revenue Share (%), By Distribution Channel - Asia-Pacific (2021)
Asia-Pacific Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
Asia-Pacific Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
China Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
China Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
China Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
China Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Japan Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Japan Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Japan Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Japan Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
India Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
India Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
India Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
India Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Southeast Asia Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Southeast Asia Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Southeast Asia Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Southeast Asia Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Australia & New Zealand Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Australia & New Zealand Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Australia & New Zealand Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Australia & New Zealand Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Asia-Pacific Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Asia-Pacific Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Asia-Pacific Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Asia-Pacific Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
08

Middle East & Africa

Based on the Middle East & Africa, the Pneumonia Treatment Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Pneumonia Treatment Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Pneumonia Treatment Size, 2019-2027 (Us$ Mn)
Middle East & Africa Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Middle East & Africa Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Middle East & Africa Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Middle East & Africa Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Middle East Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Middle East Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Middle East Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Middle East Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Africa Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Africa Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Africa Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Africa Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Middle East & Africa Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Middle East & Africa Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Middle East & Africa Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Middle East & Africa Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
09

Latin America

  • In 2021, Latin America segment accounted for US$593.81 Bn and is expected grow with a CAGR of 6.59% over the forecast years.
  • In Latin America, Brazil accounted for US$271.43 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Argentina accounted for US$171.86 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Mexico accounted for US$78.86 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Colombia accounted for US$66.18 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Latin America accounted for US$5.48 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Latin America Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
Latin America Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
Latin America Pneumonia Treatment Market - Market Opportunity (USD million), 2019, 2021 & 2027
Latin America Pneumonia Treatment Market - Market Opportunity (USD million), 2019, 2021 & 2027
Revenue Share (%), By Drug Type - Latin America (2021)
Revenue Share (%), By Drug Type - Latin America (2021)
Revenue Share (%), By Distribution Channel - Latin America (2021)
Revenue Share (%), By Distribution Channel - Latin America (2021)
Latin America Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
Latin America Pneumonia Treatment Market, By Country, 2019-2027 (USD million)
Brazil Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Brazil Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Brazil Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Brazil Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Argentina Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Argentina Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Argentina Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Argentina Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Mexico Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Mexico Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Mexico Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Mexico Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Colombia Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Colombia Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Colombia Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Colombia Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Latin America Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Latin America Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Latin America Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Latin America Pneumonia Treatment Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
10

Company Analysis

  • Abbott
  • Allergan
  • Akorn Inc.
  • Baxter International Inc.
  • Lupin Pharmaceuticals Inc.
  • Mylan Inc.
  • Neopharma
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceuticals Inc.